(ELIOR) Elior SCA - Overview
Stock: Contract Catering, Cleaning, Facility Management, Maintenance, Energy Efficiency
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 46.8% |
| Relative Tail Risk | -8.70% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.17 |
| Alpha | -0.30 |
| Character TTM | |
|---|---|
| Beta | 0.011 |
| Beta Downside | 0.175 |
| Drawdowns 3y | |
|---|---|
| Max DD | 59.70% |
| CAGR/Max DD | -0.15 |
Description: ELIOR Elior SCA December 25, 2025
Elior Group SA (ticker ELIOR) is a French-based multinational that delivers contract catering and a broad suite of support services across business, education, healthcare, and industrial clients. Its core catering business operates under the Elior brand, while ancillary services-including cleaning, facility management, energy-efficiency projects, and engineering subcontracting-are marketed under the Elior Services brand.
Founded in 1991 and headquartered in Paris, the company also runs its own restaurants and point-of-sale outlets, giving it a hybrid model that blends B2B contracts with direct consumer exposure. This diversification helps buffer earnings against sector-specific downturns, but also adds complexity to cost-structure management.
Key recent metrics (FY 2023): revenue of €5.8 bn, a 4.2 % YoY increase driven largely by inflation-linked catering contracts, and an adjusted EBITDA margin of 6.8 %, up from 5.9 % the prior year. The firm’s exposure to labor-cost inflation and regulatory pressure on food safety remains a material risk, while its investment in energy-efficiency services aligns with the broader ESG-driven demand in corporate facilities management.
Sector drivers worth monitoring include the gradual recovery of corporate dining post-pandemic, the tightening of public-sector procurement standards in France and the EU, and the rising adoption of “green-catering” initiatives that could boost premium pricing power.
For a deeper quantitative view, the ValueRay platform offers a concise analyst dashboard that can help you assess Elior’s valuation relative to peers.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 67.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 3.22 > 1.0 |
| NWC/Revenue: -8.50% < 20% (prev -7.94%; Δ -0.56% < -1%) |
| CFO/TA 0.15 > 3% & CFO 571.0m > Net Income 67.5m |
| Net Debt (1.11b) to EBITDA (583.0m): 1.90 < 3 |
| Current Ratio: 0.56 > 1.5 & < 3 |
| Outstanding Shares: last quarter (252.9m) vs 12m ago -0.23% < -2% |
| Gross Margin: 15.82% > 18% (prev 0.15%; Δ 1566 % > 0.5%) |
| Asset Turnover: 281.8% > 50% (prev 233.6%; Δ 48.21% > 0%) |
| Interest Coverage Ratio: 1.51 > 6 (EBITDA TTM 583.0m / Interest Expense TTM 194.0m) |
Altman Z'' -0.02
| A: -0.24 (Total Current Assets 1.16b - Total Current Liabilities 2.06b) / Total Assets 3.78b |
| B: 0.23 (Retained Earnings 862.0m / Total Assets 3.78b) |
| C: 0.08 (EBIT TTM 292.0m / Avg Total Assets 3.79b) |
| D: 0.28 (Book Value of Equity 835.0m / Total Liabilities 2.94b) |
| Altman-Z'' Score: -0.02 = B |
Beneish M -3.05
| DSRI: 0.99 (Receivables 801.0m/675.0m, Revenue 10.69b/8.89b) |
| GMI: 0.98 (GM 15.82% / 15.43%) |
| AQI: 1.00 (AQ_t 0.57 / AQ_t-1 0.57) |
| SGI: 1.20 (Revenue 10.69b / 8.89b) |
| TATA: -0.13 (NI 67.5m - CFO 571.0m) / TA 3.78b) |
| Beneish M-Score: -3.05 (Cap -4..+1) = AA |
What is the price of ELIOR shares?
Over the past week, the price has changed by -3.51%, over one month by +0.07%, over three months by +2.30% and over the past year by +0.88%.
Is ELIOR a buy, sell or hold?
What are the forecasts/targets for the ELIOR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 3.1 | 13.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 2.7 | -1.1% |
ELIOR Fundamental Data Overview February 04, 2026
P/E Trailing = 8.4294
P/E Forward = 8.7184
P/S = 0.1179
P/B = 0.8722
Revenue TTM = 10.69b EUR
EBIT TTM = 292.0m EUR
EBITDA TTM = 583.0m EUR
Long Term Debt = 665.0m EUR (from longTermDebt, last quarter)
Short Term Debt = 531.0m EUR (from shortTermDebt, last quarter)
Debt = 1.30b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.11b EUR (from netDebt column, last quarter)
Enterprise Value = 1.83b EUR (725.3m + Debt 1.30b - CCE 195.0m)
Interest Coverage Ratio = 1.51 (Ebit TTM 292.0m / Interest Expense TTM 194.0m)
EV/FCF = 5.58x (Enterprise Value 1.83b / FCF TTM 329.0m)
FCF Yield = 17.94% (FCF TTM 329.0m / Enterprise Value 1.83b)
FCF Margin = 3.08% (FCF TTM 329.0m / Revenue TTM 10.69b)
Net Margin = 0.63% (Net Income TTM 67.5m / Revenue TTM 10.69b)
Gross Margin = 15.82% ((Revenue TTM 10.69b - Cost of Revenue TTM 9.00b) / Revenue TTM)
Gross Margin QoQ = 15.80% (prev 17.40%)
Tobins Q-Ratio = 0.49 (Enterprise Value 1.83b / Total Assets 3.78b)
Interest Expense / Debt = 5.29% (Interest Expense 69.0m / Debt 1.30b)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 219.0m (EBIT 292.0m * (1 - 25.00%))
Current Ratio = 0.56 (Total Current Assets 1.16b / Total Current Liabilities 2.06b)
Debt / Equity = 1.56 (Debt 1.30b / totalStockholderEquity, last quarter 835.0m)
Debt / EBITDA = 1.90 (Net Debt 1.11b / EBITDA 583.0m)
Debt / FCF = 3.37 (Net Debt 1.11b / FCF TTM 329.0m)
Total Stockholder Equity = 815.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.78% (Net Income 67.5m / Total Assets 3.78b)
RoE = 8.28% (Net Income TTM 67.5m / Total Stockholder Equity 815.0m)
RoCE = 19.73% (EBIT 292.0m / Capital Employed (Equity 815.0m + L.T.Debt 665.0m))
RoIC = 11.15% (NOPAT 219.0m / Invested Capital 1.96b)
WACC = 4.68% (E(725.3m)/V(2.03b) * Re(5.96%) + D(1.30b)/V(2.03b) * Rd(5.29%) * (1-Tc(0.25)))
Discount Rate = 5.96% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 81.65 | Cagr: 0.04%
[DCF Debug] Terminal Value 88.30% ; FCFF base≈281.0m ; Y1≈341.5m ; Y5≈561.7m
Fair Price DCF = 60.35 (EV 16.38b - Net Debt 1.11b = Equity 15.27b / Shares 253.1m; r=5.90% [WACC]; 5y FCF grow 23.0% → 2.90% )
EPS Correlation: 51.64 | EPS CAGR: 9.70% | SUE: 0.0 | # QB: 0
Revenue Correlation: 60.38 | Revenue CAGR: 36.66% | SUE: -0.05 | # QB: 0
EPS current Year (2026-09-30): EPS=0.36 | Chg30d=-0.003 | Revisions Net=+0 | Growth EPS=-17.8% | Growth Revenue=+2.6%
EPS next Year (2027-09-30): EPS=0.43 | Chg30d=-0.004 | Revisions Net=-2 | Growth EPS=+18.2% | Growth Revenue=+3.4%